DK2833899T3 - Sammensætninger, der omfatter cocktails af antibakterielle fager, og anvendelser deraf til behandling af bakterieinfektioner - Google Patents
Sammensætninger, der omfatter cocktails af antibakterielle fager, og anvendelser deraf til behandling af bakterieinfektioner Download PDFInfo
- Publication number
- DK2833899T3 DK2833899T3 DK13725496.7T DK13725496T DK2833899T3 DK 2833899 T3 DK2833899 T3 DK 2833899T3 DK 13725496 T DK13725496 T DK 13725496T DK 2833899 T3 DK2833899 T3 DK 2833899T3
- Authority
- DK
- Denmark
- Prior art keywords
- antibacterial
- subjects
- applications
- treatment
- bacterial infections
- Prior art date
Links
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B2017/320004—Surgical cutting instruments abrasive
- A61B2017/320008—Scrapers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Surgery (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261612531P | 2012-03-19 | 2012-03-19 | |
| PCT/PT2013/000016 WO2013141730A1 (en) | 2012-03-19 | 2013-03-19 | Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2833899T3 true DK2833899T3 (da) | 2020-09-28 |
Family
ID=48534472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13725496.7T DK2833899T3 (da) | 2012-03-19 | 2013-03-19 | Sammensætninger, der omfatter cocktails af antibakterielle fager, og anvendelser deraf til behandling af bakterieinfektioner |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9962419B2 (enExample) |
| EP (1) | EP2833899B1 (enExample) |
| JP (1) | JP6186427B2 (enExample) |
| CN (1) | CN104519893B (enExample) |
| AU (1) | AU2013235883B2 (enExample) |
| BR (1) | BR112014023321B1 (enExample) |
| CA (1) | CA2867418C (enExample) |
| DK (1) | DK2833899T3 (enExample) |
| ES (1) | ES2814024T3 (enExample) |
| PT (1) | PT2833899T (enExample) |
| RU (1) | RU2654596C2 (enExample) |
| SG (1) | SG11201405829WA (enExample) |
| WO (1) | WO2013141730A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2865383A1 (en) * | 2013-10-25 | 2015-04-29 | Pherecydes Pharma | Phage therapy of pseudomonas infections |
| WO2016066722A2 (en) * | 2014-10-28 | 2016-05-06 | Ian Humphery-Smith | Bacteriophage combinations for human or animal therapy |
| US10455983B2 (en) | 2015-09-10 | 2019-10-29 | Prince Castle LLC | Modular food holding system |
| US20170157186A1 (en) * | 2015-12-02 | 2017-06-08 | Smart Phage, Inc. | Phage to treat bacteria on skin |
| WO2017180862A1 (en) * | 2016-04-13 | 2017-10-19 | Northeast Ohio Medical University | Gpnmb compositions for treatment of skin wounds |
| WO2018106135A2 (en) | 2016-12-05 | 2018-06-14 | Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa | Bacteriophage compositions comprising respiratory antibacterial phages and methods of use thereof |
| JP7370867B2 (ja) | 2017-02-13 | 2023-10-30 | アルマタ・ファーマシューティカルズ・インコーポレーテッド | 療法バクテリオファージ組成物 |
| US20210065844A1 (en) * | 2017-09-05 | 2021-03-04 | Adaptive Phage Therapeutics, Inc. | Methods to determine the sensitivity profile of a bacterial strain to a therapeutic composition |
| MX2020004251A (es) * | 2017-10-19 | 2021-05-27 | Mona E Buice | Composición tópica para cicatrización mejorada de heridas abiertas. |
| CA3085314A1 (en) * | 2017-12-11 | 2019-06-20 | Adaptive Phage Therapeutics, Inc. | Phage dispensing system |
| JP2021508740A (ja) * | 2018-01-02 | 2021-03-11 | アルマタ・ファーマシューティカルズ・インコーポレーテッド | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ感染症を処置するための治療的バクテリオファージ組成物 |
| CN109082414B (zh) * | 2018-06-29 | 2020-11-13 | 浙江工业大学 | 一种金黄色葡萄球菌噬菌体及应用 |
| MX2021000889A (es) | 2018-07-24 | 2021-04-28 | Medimmune Llc | Anticuerpo dirigido contra el factor de agregación a (clfa) de s. aureus. |
| CN109730235A (zh) * | 2019-02-01 | 2019-05-10 | 珠海横琴普罗恩能医用食品有限公司 | 一种用于医用食品的防腐剂 |
| US12576118B2 (en) | 2019-05-21 | 2026-03-17 | University of Pittsburgh—of the Commonwealth System of Higher Education | Bacteriophages for the treatment of tuberculosis |
| JP2023523319A (ja) | 2020-04-27 | 2023-06-02 | アルマタ・ファーマシューティカルズ・インコーポレーテッド | シュードモナス感染症を処置するためのバクテリオファージ組成物 |
| CN111643724B (zh) * | 2020-07-01 | 2022-01-28 | 南京大学 | 一种载有噬菌体和酸性成纤维细胞生长因子的水凝胶伤口敷料的制备方法及其应用 |
| WO2022013314A1 (en) | 2020-07-14 | 2022-01-20 | Biontech R&D (Austria) Gmbh | Bacteriophage cocktails and uses thereof |
| WO2022013318A1 (en) | 2020-07-14 | 2022-01-20 | Biontech R&D (Austria) Gmbh | New mosaic bacteriophages and uses thereof |
| CN112251439B (zh) * | 2020-10-26 | 2022-06-21 | 齐鲁师范学院 | 拟南芥高温诱导启动子pHTG1及其重组载体 |
| CN112301001B (zh) * | 2020-11-03 | 2022-10-14 | 华中农业大学 | 金黄色葡萄球菌噬菌体lsa2311及其应用 |
| CN113201458B (zh) * | 2020-12-21 | 2022-05-27 | 青岛诺安百特生物技术有限公司 | 一种提高噬菌体制剂稳定性的组合物及其应用 |
| AU2022272135A1 (en) * | 2021-05-12 | 2024-01-04 | Biomx Ltd. | Staphylococcus bacteriophage and uses thereof |
| WO2022261498A1 (en) * | 2021-06-11 | 2022-12-15 | Integrated Pharma Services, Llc | Device and methods for acne therapeutics: antibacterial bacteriophages and engineered lysins |
| DE202022102100U1 (de) | 2022-04-20 | 2022-04-27 | Prabhakar Ramesh Bhandari | Synergistische antibiotische pharmazeutische Zusammensetzung zur Behandlung von Staphylococcus aureus-Infektionen |
| EP4626449A1 (en) * | 2022-11-28 | 2025-10-08 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Acinetobacter baumannii phages |
| WO2025104708A1 (en) | 2023-11-16 | 2025-05-22 | Technophage, Investigação E Desenvolvimento Em Biotecnologia, S.A. | Method for determining the susceptibility of bacteria to bacteriophages |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU699322B2 (en) | 1994-04-05 | 1998-12-03 | Exponential Biotherapies, Inc. | Antibacterial therapy with genotypically modified bacteriophage |
| US5863560A (en) | 1996-09-11 | 1999-01-26 | Virotex Corporation | Compositions and methods for topical application of therapeutic agents |
| US6138401A (en) | 1999-06-25 | 2000-10-31 | Duncan; Franklin R. | Fish hook remover |
| CN1643139A (zh) * | 2002-03-25 | 2005-07-20 | 沃里克大学 | 抗菌剂 |
| US20050095222A1 (en) | 2003-10-29 | 2005-05-05 | Taro Suzuki | Allergen inhibitor, allergen-inhibiting method, allergen-inhibiting fiber and allergen-inhibiting sheet |
| EP1812025B1 (en) | 2004-11-02 | 2012-09-05 | Chr. Hansen A/S | Stabilized bacteriophage formulations |
| MX2007005279A (es) | 2004-11-02 | 2008-03-11 | Gangagen Life Sciences Inc | Composiciones de bacteriofagos. |
| CA2593992A1 (en) | 2004-12-06 | 2006-06-15 | Rodney M. Donlan | Inhibition of biofilm formation using bacteriophage |
| US20080260697A1 (en) | 2005-05-26 | 2008-10-23 | Gangagen Life Sciences Inc. | Bacterial Management in Animal Holding Systems |
| ES2761835T3 (es) * | 2009-02-06 | 2020-05-21 | Technophage Investig E Desenvolvimento Em Biotecnologia Sa | Fagos antibacterianos, péptidos de fagos y métodos de uso de los mismos |
| PT104837A (pt) | 2009-11-24 | 2011-05-24 | Technophage Investiga O E Desenvolvimento Em Biotecnologia S A | P?ptidos de fagos enteroc?cicos e m?todos para a sua utiliza??o |
| RU2614114C2 (ru) * | 2010-09-17 | 2017-03-22 | Текнифар-Индустриа Текника Фармасьютика, С.А | Бактериофаги, фаговые пептиды и способы их применения |
-
2013
- 2013-03-19 US US14/385,828 patent/US9962419B2/en active Active
- 2013-03-19 JP JP2015501614A patent/JP6186427B2/ja active Active
- 2013-03-19 SG SG11201405829WA patent/SG11201405829WA/en unknown
- 2013-03-19 EP EP13725496.7A patent/EP2833899B1/en active Active
- 2013-03-19 DK DK13725496.7T patent/DK2833899T3/da active
- 2013-03-19 AU AU2013235883A patent/AU2013235883B2/en active Active
- 2013-03-19 WO PCT/PT2013/000016 patent/WO2013141730A1/en not_active Ceased
- 2013-03-19 CN CN201380022586.5A patent/CN104519893B/zh active Active
- 2013-03-19 CA CA2867418A patent/CA2867418C/en active Active
- 2013-03-19 ES ES13725496T patent/ES2814024T3/es active Active
- 2013-03-19 RU RU2014141941A patent/RU2654596C2/ru active
- 2013-03-19 BR BR112014023321-7A patent/BR112014023321B1/pt active IP Right Grant
- 2013-03-19 PT PT137254967T patent/PT2833899T/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2867418C (en) | 2020-03-10 |
| SG11201405829WA (en) | 2014-10-30 |
| BR112014023321A2 (pt) | 2022-02-01 |
| AU2013235883A1 (en) | 2014-10-02 |
| CN104519893A (zh) | 2015-04-15 |
| RU2654596C2 (ru) | 2018-05-21 |
| EP2833899B1 (en) | 2020-06-24 |
| WO2013141730A1 (en) | 2013-09-26 |
| US9962419B2 (en) | 2018-05-08 |
| HK1207002A1 (en) | 2016-01-22 |
| EP2833899A1 (en) | 2015-02-11 |
| RU2014141941A (ru) | 2016-05-20 |
| PT2833899T (pt) | 2020-09-15 |
| AU2013235883B2 (en) | 2018-01-04 |
| JP6186427B2 (ja) | 2017-08-23 |
| CA2867418A1 (en) | 2013-09-26 |
| ES2814024T3 (es) | 2021-03-25 |
| US20150150919A1 (en) | 2015-06-04 |
| BR112014023321B1 (pt) | 2022-06-14 |
| JP2015512384A (ja) | 2015-04-27 |
| CN104519893B (zh) | 2020-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3403669T3 (da) | Fremgangsmåder til behandling og forebyggelse af staphylococcus aureus-infektioner og forbundne tilstande | |
| DK3251678T3 (da) | Benzoxaborolderivater til behandling af bakterieinfektioner | |
| DK3313421T3 (da) | Sammensætninger omfattende en bakteriestamme af blautia hydrogenotrophica til anvendelse i behandlingen af bakterielle infektioner af gastrointestinalkanalen | |
| DK3628161T3 (da) | Synergistiske bakterielle sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf | |
| DK3291679T3 (da) | Ændring af mikrobielle populationer og modificering af mikrobiota | |
| DK2898061T3 (da) | Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande | |
| ME03003B (me) | Kompozicije koje sadrže bakterijske sojeve | |
| PT3380108T (pt) | Composições bacterianas concebidas | |
| DK2729151T3 (da) | Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf | |
| DK2699553T3 (da) | Substituerede diaminocarboxamid- og diaminocarbonitrilpyrimidiner, sammensætninger deraf og fremgangsmåder til behandling dermed | |
| DK3252160T3 (da) | Systemer, fremgangsmåder og sammensætninger med crispr-cas-bestanddele til sekvensmanipulation | |
| DK2852391T3 (da) | Systemer til behandling af lungeinfektioner | |
| BR112015001838A2 (pt) | composições de inibidor de efluxo e métodos de tratamento utilizando o mesmo. | |
| DK3444268T3 (da) | Staphylococcus aureus-leukocidiner, terapeutiske sammensætninger og anvendelser deraf | |
| DK4000608T3 (da) | Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf | |
| DK3378862T3 (da) | Dihydropyrimidinoisoquinolinoner og farmaceutiske sammensætninger deraf til behandlingen af multipel sklerose | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| DK2925293T3 (da) | Topiske tetracyclinformuleringer, fremstilling og anvendelser deraf | |
| DK2763665T3 (da) | Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf | |
| DK3220741T3 (da) | Sammensætning og kits til hæmning af patogen mikrobiel infektion og fremgangsmåder til anvendelse af samme | |
| SG11201405829WA (en) | Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections | |
| DK2903967T3 (da) | Acylaminopyrimidinderivater til behandling af virusinfektioner og yderligere sygdomme | |
| DK2961835T3 (da) | Ny bakteriophag og antibakteriel sammensætning omfattende samme | |
| DK3238707T3 (da) | Sammensætninger og fremgangsmåder til behandling af intestinal hyperpermeabilitet | |
| DK2849782T3 (da) | Bacteriophag lysin og antibiotiske sammensætninger imod gram-positive bakterier |